4 PBAC submissions on file, active 2023–2025. 75% have been recommended.
Submissions
4
2023 → 2025
Win rate
75 %
3 recommended of 4 bucketable
Drugs
4 · 3 listed
unique molecules submitted
PBS spend captured
—
FY-latest govt benefit on owned drugs
Drug portfolio
Sorted by PBS spend captured. PBS expenditure is credited to the sponsor with the most recent Recommended decision per drug, so biosimilars and originator brands aren't double-counted.